SEC Filings - MiNK Therapeutics

Form	Description	Filing date	View
CORRESP	CORRESP	Oct 12, 2021	View HTML 0001193125-21-296966.pdf 0001193125-21-296966.rtf 0001193125-21-296966.xls
CORRESP	CORRESP	Oct 12, 2021	View HTML 0001193125-21-296972.pdf 0001193125-21-296972.rtf 0001193125-21-296972.xls
8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	Oct 13, 2021	View HTML 0001193125-21-297781.pdf 0001193125-21-297781.rtf 0001193125-21-297781.xls
EFFECT	EFFECT	Oct 14, 2021	View HTML 9999999995-21-003881.pdf 9999999995-21-003881.rtf 9999999995-21-003881.xls
FWP	FWP	Oct 15, 2021	View HTML 0001193125-21-299060.pdf 0001193125-21-299060.rtf 0001193125-21-299060.xls
424B4	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	Oct 15, 2021	View HTML 0001193125-21-300184.pdf 0001193125-21-300184.rtf 0001193125-21-300184.xls
8-K	Report of unscheduled material events or corporate event	Oct 20, 2021	View HTML 0001193125-21-303045.pdf 0001193125-21-303045.rtf 0001193125-21-303045.xls
3	Initial filing by director officer or owner of more than ten percent.	Oct 20, 2021	View HTML 0000899243-21-040845.pdf 0000899243-21-040845.rtf 0000899243-21-040845.xls
3	Initial filing by director officer or owner of more than ten percent.	Oct 20, 2021	View HTML 0000899243-21-040849.pdf 0000899243-21-040849.rtf 0000899243-21-040849.xls
3	Initial filing by director officer or owner of more than ten percent.	Oct 20, 2021	View HTML 0000899243-21-040854.pdf 0000899243-21-040854.rtf 0000899243-21-040854.xls

Data provided by Kaleidoscope.